DMRA – (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

DMRA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/30

08:00 am

dmra

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Medium Report

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Report

3/25

10:00 am

dmra

Damora Therapeutics, Inc. Common Stock (DMRA) is now covered by Evercore Inc. They set an "outperform" rating and a $46.00 price target on the stock.

Medium Report

Damora Therapeutics, Inc. Common Stock (DMRA) is now covered by Evercore Inc. They set an "outperform" rating and a $46.00 price target on the stock.

Report

3/23

08:00 am

dmra

Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors

High Report

Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors

Report

3/19

04:10 pm

dmra

Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

Medium Report

Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.